Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2012
06/21/2012WO2012041263A3 A method of manufacturing 2-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]- l,3-oxazolidin-5-yl}methyl)-lh-isoindol-l,3(2h)-dione with a high optical purity
06/21/2012WO2012035171A3 Sulfonamide compounds
06/21/2012WO2012027712A3 Potent and selective inhibitors of hepatitis c virus
06/21/2012WO2011051540A9 Androgen receptor modulating compounds
06/21/2012US20120157678 Methods of making fused ring compounds
06/21/2012US20120157677 Lactone compounds and materials made therefrom
06/21/2012US20120157497 Compounds having analgesic and/or immunostimulant activity
06/21/2012US20120157463 Chromone derivatives, a process for their preparation and their therapeutic applications
06/21/2012US20120157456 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
06/21/2012US20120157455 Compounds And Compositions For Treating Cancer
06/21/2012US20120157454 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
06/21/2012US20120157449 Benzofurane compounds
06/21/2012US20120157443 Bruton's tyrosine kinase inhibitors
06/21/2012US20120157438 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157433 Heteroaryl Compounds as Kinase Inhibitors
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157427 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
06/21/2012US20120157425 New compounds, pharmaceutical compositions and uses thereof
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157314 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
06/21/2012US20120156521 Photochromic compounds and compositions
06/21/2012US20120156508 Photochromic compounds and compositions
06/21/2012US20120156264 Injectable depot formulation comprising crystals of iloperidone
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012CA2818034A1 Herbicidal compositions
06/20/2012EP2465857A1 Methods for synthesizing heterocyclic compounds
06/20/2012EP2465852A1 Capped pyrazinoylguanidine sodium channel blockers
06/20/2012EP2464643A1 Microbiocidal heterocycles
06/20/2012EP2464642A1 Method of promoting apoptosis and inhibiting metastasis
06/20/2012EP2464639A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors
06/20/2012EP2464632A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors
06/20/2012EP2464228A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
06/20/2012EP2464227A1 Compounds and methods of use thereof
06/20/2012EP2227460B1 Therapeutic oxy-phenyl-aryl compounds and their use
06/20/2012EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/20/2012EP1912996B1 Macrocyclic inhibitors of hepatitis c virus
06/20/2012EP1910378B1 Hepatitis c inhibitor peptide analogs
06/20/2012EP1745041B1 Quinoxaline inhibitors of the hedgehog signalling pathway
06/20/2012CN1906183B N-acylsulfonamide apoptosis promoters
06/20/2012CN102510867A Glycoside derivative and uses thereof
06/20/2012CN102503906A Formyl hydroxylamine type peptide deformylase inhibitor containing oxazole ring, as well as preparation method and use thereof
06/20/2012CN101891678B 4-(N,N-dimethyl) aminopyridine derivate and synthesis method thereof
06/20/2012CN101302214B Aralkyl piperidine (piperazidine) derivate and use thereof in mental disease treatment
06/19/2012US8203001 Chemical compounds
06/19/2012US8202876 Compounds and compositions as protein kinase inhibitors
06/19/2012US8202865 Oxadiazole derivatives
06/19/2012US8202864 Compounds
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012US8202857 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1
06/19/2012US8202856 Triazole oxadiazoles derivatives
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012077051A1 Hydroxylated aminotriazole derivatives as alx receptor agonists
06/14/2012WO2012077049A1 Oxazolyl-methylether derivatives as alx receptor agonists
06/14/2012WO2012076898A1 Triazole derivatives as wnt signaling pathway inhibitors
06/14/2012WO2012076877A1 Hydantoin derivatives useful as kv3 inhibitors
06/14/2012WO2012076704A2 Pyrazole compounds for controlling invertebrate pests
06/14/2012WO2012076673A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012WO2012076672A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
06/14/2012WO2012076590A1 Novel triazole compounds iii
06/14/2012WO2012076435A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
06/14/2012WO2012076063A1 Pyridine amide derivatives as ep4 receptor antagonists
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012WO2011072241A9 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters
06/14/2012US20120149900 Fluorine containing compounds and methods of use thereof
06/14/2012US20120149718 Amido Compounds
06/14/2012US20120149715 Compounds and methods for the treatment of viral infections
06/14/2012US20120149706 Inhibition of p38 kinase activity using substituted heterocyclic ureas
06/14/2012US20120149705 N-Thio-anthranilamid compounds and their use as pesticides
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149697 Humic substances and therapeutic uses thereof
06/14/2012US20120149695 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
06/14/2012US20120149694 Substituted piperidines
06/14/2012US20120149687 Heterocyclic compounds and uses thereof
06/14/2012US20120149686 Kinase inhibitors and method of treating cancer with same
06/14/2012US20120149683 Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
06/14/2012US20120149676 Novel compounds
06/14/2012US20120149675 1,2,3-triazole-imidazolecompounds
06/14/2012US20120149674 Diaryl Substituted Alkanes
06/14/2012US20120149661 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
06/14/2012US20120149573 Herbicidal bus-nitrogen-containing oxo and sulfono heterocycles
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120145975 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
06/14/2012US20120145973 Photochromic Materials That Include Indeno-Fused Naphthopyrans
06/14/2012CA2820838A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012CA2820800A1 Triazole derivatives as wnt signaling pathway inhibitors
06/14/2012CA2820408A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp-pla2
06/14/2012CA2820109A1 Pyridine amide derivatives as ep4 receptor antagonists
06/14/2012CA2820044A1 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/14/2012CA2819889A1 Substituted pyridinone-pyridinyl compounds
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/14/2012CA2819277A1 Novel triazole compounds iii
06/14/2012CA2817205A1 Hydantoin derivatives useful as kv3 inhibitors
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 647